Liu Dongwu, Chen Jie, Gao Mingli, Yu Jing
Department of Rheumatology and Immunology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China.
College of Integrative Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Oct 18;56(5):928-931. doi: 10.19723/j.issn.1671-167X.2024.05.028.
Rheumatoid arthritis (RA) is a common chronic autoimmune inflammatory disease, characterized by persistent polyarthritis. Patients with RA may exhibit varying degrees of B lymphocyte activation, clinically manifested as enlarged lymph nodes. Disease-modifying anti-rheumatic drugs and glucocorticoid are often used to treat RA. Biological agents targeting tumor necrosis factor alpha, interleukin-6(IL-6), and B lymphocytes are often used to treat rheumatoid arthritis. Castleman disease (CD) is a rare benign lymphoproliferative disorder. Histopathological examination is the most important method to diagnose this disease. Based on the different lymph node involvement areas CD can be divided into unicentric CD(UCD) and multicentric CD(MCD). Surgical removal of lymph nodes is a common treatment method for UCD. MCD often requires chemotherapeutic drugs combined with glucocorticoid therapy. For the most recent years, biological agents targeting IL-6 and B lymphocytes have shown good curative effects on CD. In the past, patients with rheumatic immune disease accompanied by Castleman like histopathology in lymph nodes were commonly referred to as rheumatic immune disease combined with CD. In 2021, experts unanimously agreed that autoimmune diseases with Castleman like lymphadenopathy should be diagnosed as rheumatic autoimmune diseases with Castleman like histopathology in lymph nodes. This report introduces a 65-year-old female patient with rheumatoid arthritis who was admitted to the hospital due to joint swelling and pain. Physical and chemical examinations after admission showed that rheumatoid arthritis was in an active phase. Chest CT revealed multiple enlarged lymph nodes in the right armpit. Then it was removed by surgery. The histopathological report showed that the lymphatic sinus disappeared, the lymphoid tissue proliferated, the lymphoid follicles increased, and the size was inconsistent. The small lymphocytes around the germinal centers of some follicles were concentric circles, and the follicular interstitial blood vessels proliferated. She was diagnosed with rheumatoid arthritis with Castleman like histopathology in lymph nodes and was treated with methotrexate and hydroxychloroquine sulfate combined with glucocorticoids. The patient was followed up for 2 years. In the first year after sur-gery, the patient' s condition remained stable and there was no growth of lymph nodes in the right axilla. The patient passed away due to severe infection in the second year after the surgery.
类风湿关节炎(RA)是一种常见的慢性自身免疫性炎症性疾病,其特征为持续性多关节炎。类风湿关节炎患者可能表现出不同程度的B淋巴细胞活化,临床表现为淋巴结肿大。改善病情抗风湿药和糖皮质激素常用于治疗类风湿关节炎。靶向肿瘤坏死因子α、白细胞介素-6(IL-6)和B淋巴细胞的生物制剂常用于治疗类风湿关节炎。Castleman病(CD)是一种罕见的良性淋巴增殖性疾病。组织病理学检查是诊断该病的最重要方法。根据淋巴结受累区域不同,Castleman病可分为单中心Castleman病(UCD)和多中心Castleman病(MCD)。手术切除淋巴结是单中心Castleman病的常见治疗方法。多中心Castleman病通常需要化疗药物联合糖皮质激素治疗。近年来,靶向IL-6和B淋巴细胞的生物制剂对Castleman病显示出良好疗效。过去,风湿免疫病患者伴有淋巴结Castleman样组织病理学表现的,通常被称为风湿免疫病合并Castleman病。2021年,专家们一致认为,伴有Castleman样淋巴结病的自身免疫性疾病应诊断为伴有淋巴结Castleman样组织病理学表现的风湿性自身免疫性疾病。本报告介绍了一名65岁女性类风湿关节炎患者,因关节肿胀疼痛入院。入院后理化检查显示类风湿关节炎处于活动期。胸部CT显示右腋窝多发肿大淋巴结。随后进行了手术切除。组织病理学报告显示淋巴窦消失,淋巴组织增生,淋巴滤泡增多且大小不一。部分滤泡生发中心周围的小淋巴细胞呈同心圆状,滤泡间质血管增生。她被诊断为伴有淋巴结Castleman样组织病理学表现的类风湿关节炎,并接受了甲氨蝶呤、硫酸羟氯喹联合糖皮质激素治疗。对该患者进行了2年随访。术后第一年,患者病情保持稳定,右腋窝淋巴结无增大。患者在术后第二年因严重感染去世。